Article
Identification of key gene signatures for the overall survival of ovarian cancer
20 Jan 2022
Abstract excerpt
BACKGROUND: The five-year overall survival (OS) of advanced-stage ovarian cancer remains nearly 25-35%, although several treatment strategies have evolved to get better outcomes. A considerable amount of heterogeneity and complexity has been seen in ovarian cancer. This study aimed to establish gene signatures that can be used in better prognosis through risk prediction outcome for the survival of ovarian cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
